StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.51+0.01 (+2.27%)

Close on Nov 20, 2026Market cap $13.96MP/E –Yield –

Citius Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Citius Pharmaceuticals's revenue for the twelve months ending Sep 30, 2022 was $90.00K, up 0.0% year over year. For fiscal 2022 it was $90.00K, up 0.0% from the year before. The highest annual figure on record is $90.00K in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2022Sep 30, 2022$90.00K0.0%
FY2021Sep 30, 2021$90.00K0.0%
FY2020Sep 30, 2020$90.00K0.0%
FY2019Sep 30, 2019$90.00K+20.0%
FY2018Sep 30, 2018$75.00K+50.0%
FY2017Sep 30, 2017$50.00K–
FY2012Sep 30, 2012$0–
FY2011Sep 30, 2011$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$1.49M–
Q2 FY2026CQ1 2026Mar 31, 2026$1.67M–
Q1 FY2026CQ4 2025Dec 31, 2025$3.94M–
Q4 FY2022CQ3 2022Sep 30, 2022$0–
Q4 FY2021CQ3 2021Sep 30, 2021$0–
Q4 FY2020CQ3 2020Sep 30, 2020$0–
Q4 FY2019CQ3 2019Sep 30, 2019$0–
Q4 FY2018CQ3 2018Sep 30, 2018$0–

More Citius Pharmaceuticals figures

See a number that looks wrong?